Herein, we aimed to detect the expression of CTLA-4, CD86, CD4, and CD8 in surgical specimens from RC patients after nCRT/nCT, and to classify CD4+ and CD8+ cells into stroma, tumor, and invasive categories according to their location. This evidence concerns the gene CD86 and neoplasm.